Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)

Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)

US Patent 9828352 · Granted Nov 28, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrazole derivatives for the treatment of cystic fibrosis2025
Compounds and compositions for the treatment of tumors2025
Compounds and compositions for the treatment of cystic fibrosis2025
Pyrazole derivatives as H4 antagonist compounds2025
Peptide inhibitors targeting the CXCL12/HMGB1 interaction and uses thereof2024
Compounds and compositions for the treatment of cystic fibrosis2024
Compounds for the modulation of cyclophilins function2023
Pyrazole derivatives for the treatment of cystic fibrosis2023
Methods using fingerprint and evolution analysis2022
Compounds and compositions for the treatment of cystic fibrosis2021
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions2020
Heterocyclic derivatives for the treatment of cystic fibrosis2020